Application 071055
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLOXURIDINE | FLOXURIDINE | Injectable; Injection | 500MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Floxuridine | FLOXURIDINE | Fresenius Kabi USA, LLC | c8edabc1-67cd-421b-a147-7c1f19f05b8e | 2024-10-14 | Warnings, Adverse reactions | Floxuridine FLOXURIDINE |
| Floxuridine | FLOXURIDINE | JND Therapeutics, Inc. | 4681f23e-6b5e-433b-b245-3d0b4e64ebb2 | 2024-10-07 | Boxed warning, Warnings, Adverse reactions | Floxuridine FLOXURIDINE |
| Floxuridine | FLOXURIDINE | Hikma Pharmaceuticals USA Inc. | e3c2e3e7-bc83-465d-b615-3ad56580b3a7 | 2023-05-15 | Boxed warning, Warnings, Adverse reactions | Floxuridine FLOXURIDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.